PRG-138-C1(54806-63-2)
- Name: PRG-138-C1
- Synonyms:1,2,3-Oxadiazolium,5-[(cyclohexylcarbonyl)amino]-3-(4-morpholinyl)-, chloride, hydrochloride(9CI); Sydnone imine, N-(cyclohexylcarbonyl)-3-(4-morpholinyl)-, hydrochloride;Cyclosidimine; PRG 138
- Molecular Formula:C13H21 N4 O3 . x Cl H . Cl
- Molecular Weight:353.24478
- CAS Registry Number:54806-63-2
- EINECS:
- Melting Point:
- Water Solubility:
CAS No.54806-63-2 PRG-138-C1
Assay:99.0% Appearance:liquid Package:Grams, Kilograms Storage:Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials. Transportation:According to customer request Application:For R&D and commerical use
Min. Order:100Gram
Supplier:Chemlyte Solutions [
China (Mainland)] CAS No.54806-63-2 PRG-138-C1
Assay:99% Application:Fine chemical intermediates, used as the main raw material for the synthesis of various pesticides, medicines, surfactants, polymer monomers, and antifungal agents
Min. Order:0
Supplier:Zibo Hangyu Biotechnology Development Co., Ltd [
China (Mainland)] CAS No.54806-63-2 PRG-138-C1
Assay:99% Package:box or opp package Storage:cool drum Transportation:air or sea Application:PRG-138-C1
Min. Order:1Milligram
Supplier:weifang yangxu group co.,ltd [
China (Mainland)]
Other Product
- 208997-58-4/7H-Furo[3,2-g][1]benzopyran-7-one,9-[[(2S,- 4S)-9'-[(2R)-2,3-dihydroxy-3-methylbutoxy]- 5,5-dimethylspiro[1,3-dioxolane-2,7'-[7H]furo- [3,2-g][1]benzopyran]-4-yl]methoxy]-
- 16984-59-1/URANYL FORMATE
- 143107-96-4/80K protein
- 27588-42-7/3-[4-(2-methoxy-2-phenylethyl)piperazin-1-yl]-1-(3,4,5-trimethoxyphenyl)propan-1-ol dihydrochloride
- 57537-18-5/1-(4-fluorophenyl)-4-[4-(5,6,7,8-tetrahydronaphthalen-2-yl)piperazin-1-yl]butan-1-one (2Z)-but-2-enedioate
- 72758-48-6/(2S,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxy-N-[2-hydroxy-3-(3-methylphenoxy)propyl]tetrahydrofuran-2-carboxamide (non-preferred name)
- 631-05-0/23-Norcon-5-enin-3-amine,N,N-dimethyl-,(3â)-
- 204514-78-3/6H,14aH-3a,5a-Ethano-5,12-methano-1H-[1,- 3]dioxolo[4,5-a]indolizino[1,8-fg]carbazole-6- carboxylic acid,2,3,4,5,12,13-hexahydro-5- hydroxy-13,15-dioxo-,methyl ester,(3aR,5S,5aS,11bR,12S,14aS)-
- 68213-36-5/Fatty acids, C18-unsatd., dimers, polymers with ethylene glycol, linseed-oil fatty acids, pentaerythritol, phthalic anhydride, rosin and tall-oil fatty acids
- 71808-53-2/Quaternary ammonium compounds, C12-18-alkylbis(hydroxyethyl)methyl,chlorides
- 78214-15-0/2-[4-(4-Hydroxyphenyl)-1,3-butadienyl]-4H-3,1-benzoxazin-4-one
- 65060-80-2/Iron alloy,base,Fe 68-70,Cr 26-28,C 2.6-2.8,Mn 0.6-0.8,Si 0.6-0.8 (270Kh27)
- 74148-46-2/mitomycin G
- 15304-14-0/hexakis(urea-O)aluminium(3+) triiodide sulphate
- 58318-77-7/Nalcotrol
- 69008-24-8/1-Amino-9,10-dihydro-4-[[3-[[(4-methylphenyl)sulfonyl]amino]phenyl]amino]-9,10-dioxo-2-anthracenesulfonic acid sodium salt
- 54484-26-3/O,O-dibutyl dihydrogen thiodiphosphate
- 132923-13-8/3-Pyridinedodecanamine,ç-methyl-,(çS)-
- 100929-53-1/DAGO ACETATE SALT
- 54806-63-2/PRG-138-C1
- 93798-26-6/RCE 8
- 19848-54-5/1-(3-Methylpyrazin-2-yl)hydrazine
- 1331-87-9/CALCIUM CAMPHORSULFONATE
- 55037-65-5/1-methyl-4-(6,7,8,9-tetrahydro-5H-benzo[7]annulen-2-ylmethyl)piperazine di[(2E)-but-2-enedioate]
- 68788-55-6/5-(4-methylphenyl)-1,3-thiazolidine-2-thione
- 122007-85-6/Plasminogen activator(human tissue-type protein moiety reduced), 84-L-serine- (9CI)
- 135-54-6/2,5-DIMETHOXY-BENZYL-HYDRAZINE
- 472-54-8/19-NORPROGESTERONE
- 2217-55-2/BIS(2,4-DINITROPHENYL) DISULFIDE
- 61397-58-8/KETOCONAZOLE INTERMEDIATE